Efficacy of Cellfood®'s therapy (deutrosulfazyme) in fibromyalgia;Efficacia del trattamento con Cellfood (deutrosulfazyme) nella fibromialgia

Reumatismo

Volumn 59, Issue 4, 2007, Pages 316-321

  Nieddu, Maria Elena ^a   Menza, L ^b   Baldi, F ^a   Frediani, B ^b   Marcolongo, R ^a  

^a Servizio di Reumatologia Clinica Rugani G Sante   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Cellfood ; Fibromyalgia; Health related quality of life

Indexed keywords

DEUTROSULFAZYME; ENZYME; ION; PLACEBO; UNCLASSIFIED DRUG; AMINO ACID; ANTIOXIDANT; CELLFOOD; DEUTERIUM; MINERAL; SULFATE;

ADULT; ALGOMETER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; FEMALE; FIBROMYALGIA; GENERAL CONDITION IMPROVEMENT; HEALTH STATUS; HUMAN; MEDICAL EXAMINATION; PATIENT CODING; PATIENT SELECTION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; METABOLISM; MIDDLE AGED; PAIN ASSESSMENT; SYNTHESIS; TREATMENT OUTCOME;

ADULT; AMINO ACIDS; ANTIOXIDANTS; CROSS-OVER STUDIES; DEUTERIUM; ENZYMES; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; MINERALS; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRES; SINGLE-BLIND METHOD; SULFATES; TREATMENT OUTCOME;

EID: 55449105783     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Aldo C, Marco T. La riabilitazione integrata delle Malattie Reumatiche, Masson Editore 2006; Fibromialgia: 275-6.
2. Bennet R. Fibromyalgia: present to future. Curr Rheumatol Rep 2005; 7: 371-6.
3. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know and what we need to know. Best Pract Res Clin Rheumatol 2003; 17: 685-701.
4. Wolfe F, Smythe HA, Yunus MB, Bennet RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Artrhitis Rheum 1990; 33: 160-72.
5. Wolfe F, Ross K, Anderson J, Russel U. Aspects of fibromyalgia in the general population: sex, pain threshold and fibromyalgia symptoms. J Rheumatol. 1995; 22: 151-6.
6. Thompson D, Lettich L, Takeshita J. Fibromyalgia: an overview. Curr Psychiatry Rep 2003; 5: 211-17.
7. Yunus MB, Khan MA, Rawlings KK. Genetic linkage analysis of multicase familes with fibromyalgia syndrome. J Rheumatol 1999; 26: 408-12.
8. Seton M, Polisson R. Fibromyalgia and regional pain syndromes. In: Carr PL, Somani S Eds. The medical care women. Philadelphia: WB saunders, 1995; 578-88.
9. Wortmann RL. Searching for the cause of fibromyalgia: is there a defect in energy metabolism? Artrhitis Rheum 1994; 37: 790-3.
10. Iorio EL. Deutrosulfazyme (Cellfood®). Overview clinicofarmacologica. Proceeding International Conference Safety Evaluation of Complementary and Alternative Medicine, 2003; 24-5.
11. Bell IR, Lewis DA, Brooks AJ, Schwartz GE, Lewis SE, Walsh BT, et al. Improved clinical status in fibromyalgia patients treated with individualized homeopatic remedies versus placebo. Rheumatology 2004; 43: 577-82.
12. Lind BK, Lafferty WE, Tyree PT, Diehr PK, Grembowski DE. Use of Complementary and Alternative Medicine Providers by Fibromyalgia Patients Under Insurance Coverage. Arthritis Rheum. 2007; 57: 71-6.